We are live on ! Find out more
ACLX

Arcellx

Delisted

ACLX was delisted on the 27th of April, 2026.

68 hedge funds and large institutions have $622M invested in Arcellx in 2022 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 26 increasing their positions, 13 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

667% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 3

100% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 13

74% more capital invested

Capital invested by funds: $358M → $622M (+$264M)

40% more funds holding in top 10

Funds holding in top 10: 57 (+2)

39% more funds holding

Funds holding: 4968 (+19)

6.55% more ownership

Funds ownership: 75.19%81.74% (+6.5%)

Holders
68
Holders Change
+19
Holders Change %
+38.78%
% of All Funds
1.15%
Holding in Top 10
7
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+40%
% of All Funds
0.12%
New
23
Increased
26
Reduced
13
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
NMC
1
NEA Management Company
Maryland
$113M +$4.03M +312,500 +5%
SOCM
2
SR One Capital Management
Pennsylvania
$99.4M
NHAS
3
Novo Holdings A/S
Denmark
$72.6M
SCM
4
Suvretta Capital Management
New York
$44.7M +$12.1M +937,500 +61%
Citadel Advisors
5
Citadel Advisors
Florida
$31.3M +$5.81M +450,374 +34%
CAM
6
Cormorant Asset Management
Massachusetts
$27.6M +$19.7M +1,525,000 New
AIIC
7
AJU IB Investment Company
South Korea
$25M
Janus Henderson Group
8
Janus Henderson Group
United Kingdom
$22.7M +$16.2M +1,254,809 New
CCP
9
Clough Capital Partners
Massachusetts
$21M -$572K -44,343 -4%
PA
10
Perceptive Advisors
New York
$20.6M +$14.7M +1,141,990 New
SB
11
Samsara BioCapital
California
$19.2M +$827K +64,108 +6%
SCM
12
Soleus Capital Management
Connecticut
$16.4M -$1.03M -80,000 -8%
Vanguard Group
13
Vanguard Group
Pennsylvania
$12.1M +$2.95M +228,369 +52%
Fidelity Investments
14
Fidelity Investments
Massachusetts
$11.3M +$8.05M +623,705 +4,797,731%
BlackRock
15
BlackRock
New York
$10.9M +$1.32M +102,406 +20%
Adage Capital Partners
16
Adage Capital Partners
Massachusetts
$9.53M -$5.17M -400,664 -43%
Lord, Abbett & Co
17
Lord, Abbett & Co
New Jersey
$9.17M +$6.54M +506,994 New
Balyasny Asset Management
18
Balyasny Asset Management
Illinois
$7.46M +$3.37M +261,304 +173%
UBS Group
19
UBS Group
Switzerland
$3.56M -$382K -29,604 -13%
Geode Capital Management
20
Geode Capital Management
Massachusetts
$3.46M +$652K +50,558 +36%
PHP
21
Parkman Healthcare Partners
Connecticut
$3.22M +$2.3M +178,000 New
State Street
22
State Street
Massachusetts
$3.18M +$1.35M +104,812 +148%
Blackstone Inc
23
Blackstone Inc
New York
$2.61M +$1.86M +144,373 New
CCM
24
CAAS Capital Management
New York
$2.37M -$3.53M -273,412 -68%
EI
25
EAM Investors
California
$2.37M +$1.69M +130,810 New

ACLX Hedge Fund Activity: Q2 2022 in Review

68 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Arcellx (ACLX) for Q2 2022, worth a combined $622M — up 74% from $358M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new ACLX positions and 3 closed out — a net gain of 20 holders — while 26 added to existing stakes and 13 trimmed.

The largest buyer was Cormorant Asset Management, opening a new position worth an estimated $19.7M. The largest seller was Adage Capital Partners, cutting an estimated $5.17M.

  • 68 institutional investors held Arcellx (ACLX) as of Q2 2022, up from 49 in Q1 2022.
  • Funds reported $622M of Arcellx stock for Q2 2022, up 74% quarter-over-quarter.
  • 23 funds opened new Arcellx positions in Q2 2022 and 3 closed out, a net change of +20 holders.
  • The largest Arcellx buyer in Q2 2022 was Cormorant Asset Management, an estimated $19.7M added.
  • The largest Arcellx seller in Q2 2022 was Adage Capital Partners, an estimated $5.17M sold.

Based on aggregated 13F filings for Q2 2022.